AbbVie is a global biopharmaceutical company headquartered in North Chicago, Illinois. Formed in 2013 following its separation from Abbott Laboratories, AbbVie focuses on developing and delivering innovative medicines and solutions that enhance people's lives. The company's portfolio includes treatments in immunology, oncology, neuroscience, eye care, and aesthetics.

Notable products include Humira, Skyrizi, Rinvoq, Imbruvica, Venclexta, Vraylar, and Mavyret. AbbVie is committed to scientific progress, with 75% of its medicines considered first-in-kind. The company operates in over 170 countries and employs approximately 55,000 people worldwide.